Breast Cancer Clinical Trial
Official title:
Change in Mammographic Density With Metformin Use: A Companion Study to NCIC Study MA.32
RATIONALE: Learning about the effect of metformin hydrochloride in breast density of women
with early-stage breast cancer may help plan treatment.
PURPOSE: This trial studies changes in breast density in patients with early-stage breast
cancer treated with metformin hydrochloride or placebo on CAN-NCIC-MA.32.
OBJECTIVES:
Primary
- To evaluate the change in percent mammographic density in contralateral (unaffected
breast) from prior to the initiation of metformin hydrochloride (metformin) or placebo
treatment through one year of therapy in patients with hormone receptor-negative breast
cancer (i.e., not on endocrine therapy).
Secondary
- To evaluate the change in percent breast density in contralateral (unaffected breast)
from prior to the initiation of metformin or placebo treatment through two years of
therapy in patients with hormone receptor-negative breast cancer (i.e., not on
endocrine therapy).
- To evaluate whether baseline mammographic density correlates with baseline of fasting
plasma insulin, glucose levels, and Homeostasis Model Assessment (HOMA) (collected on
the treatment protocol CAN-NCIC-MA.32) (MA.32).
- To evaluate whether changes in dense area in response to metformin therapy from
pre-treatment through two years of therapy correlate with changes in fasting plasma
insulin, glucose levels, and HOMA (collected on the treatment protocol MA.32) over the
same time period.
- To explore whether change in mammographic density for women on metformin is associated
with risk of second primary breast cancer.
OUTLINE: Patients' mammograms taken at baseline and at approximately 1 and 2 years of
metformin or placebo treatment are retrieved and analyzed for breast-density change.
Pre-menopausal patients' menstrual cycle information is also collected at baseline and every
6 months for 2 years.
;
N/A
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04681911 -
Inetetamab Combined With Pyrotinib and Chemotherapy in the Treatment of HER2 Positive Metastatic Breast Cancer
|
Phase 2 | |
Terminated |
NCT04066790 -
Pyrotinib or Trastuzumab Plus Nab-paclitaxel as Neoadjuvant Therapy in HER2-positive Breast Cancer
|
Phase 2 | |
Completed |
NCT04890327 -
Web-based Family History Tool
|
N/A | |
Completed |
NCT03591848 -
Pilot Study of a Web-based Decision Aid for Young Women With Breast Cancer, During the Proposal for Preservation of Fertility
|
N/A | |
Recruiting |
NCT03954197 -
Evaluation of Priming Before in Vitro Maturation for Fertility Preservation in Breast Cancer Patients
|
N/A | |
Terminated |
NCT02202746 -
A Study to Assess the Safety and Efficacy of the VEGFR-FGFR-PDGFR Inhibitor, Lucitanib, Given to Patients With Metastatic Breast Cancer
|
Phase 2 | |
Active, not recruiting |
NCT01472094 -
The Hurria Older PatiEnts (HOPE) With Breast Cancer Study
|
||
Completed |
NCT06049446 -
Combining CEM and Magnetic Seed Localization of Non-Palpable Breast Tumors
|
||
Withdrawn |
NCT06057636 -
Hypnosis for Pain in Black Women With Advanced Breast Cancer: A Feasibility Study
|
N/A | |
Recruiting |
NCT05560334 -
A Single-Arm, Open, Exploratory Clinical Study of Pemigatinib in the Treatment of HER2-negative Advanced Breast Cancer Patients With FGFR Alterations
|
Phase 2 | |
Active, not recruiting |
NCT05501769 -
ARV-471 in Combination With Everolimus for the Treatment of Advanced or Metastatic ER+, HER2- Breast Cancer
|
Phase 1 | |
Recruiting |
NCT04631835 -
Phase I Study of the HS-10352 in Patients With Advanced Breast Cancer
|
Phase 1 | |
Completed |
NCT04307407 -
Exercise in Breast Cancer Survivors
|
N/A | |
Recruiting |
NCT03544762 -
Correlation of 16α-[18F]Fluoro-17β-estradiol PET Imaging With ESR1 Mutation
|
Phase 3 | |
Terminated |
NCT02482389 -
Study of Preoperative Boost Radiotherapy
|
N/A | |
Enrolling by invitation |
NCT00068003 -
Harvesting Cells for Experimental Cancer Treatments
|
||
Completed |
NCT00226967 -
Stress, Diurnal Cortisol, and Breast Cancer Survival
|
||
Recruiting |
NCT06019325 -
Rhomboid Intercostal Plane Block on Chronic Pain Incidence and Acute Pain Scores After Mastectomy
|
N/A | |
Recruiting |
NCT06037954 -
A Study of Mental Health Care in People With Cancer
|
N/A | |
Recruiting |
NCT06006390 -
CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors
|
Phase 1/Phase 2 |